BRAINSTORM CELL THERAPEUTICS INC.
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 1325 AVENUE OF AMERICAS, NEW YORK, NY, 10019
Mailing Address 1325 AVENUE OF AMERICAS, NEW YORK, NY, 10019
Phone 201-488-0460
Fiscal Year End 1231
EIN 207273918
Financial Overview
FY2025
$1.83M
Total Assets
$187K
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 31, 2026 | View on SEC |
| 10-K Annual financial report | March 31, 2026 | View on SEC |
| 8-K Current report of material events | February 27, 2026 | View on SEC |
| 8-K Current report of material events | February 13, 2026 | View on SEC |
| 8-K Current report of material events | January 9, 2026 | View on SEC |
| 8-K Current report of material events | November 14, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 14, 2025 | View on SEC |
| 8-K Current report of material events | November 6, 2025 | View on SEC |
| 8-K Current report of material events | August 14, 2025 | View on SEC |
| 10-Q Quarterly financial report | August 14, 2025 | View on SEC |
Annual Reports
10-K March 31, 2026
- FDA has formally agreed to the design of a new Phase 3b clinical trial for the NurOwn® ALS treatment.
- The company is focused on autologous cell therapy, harvesting patient stem cells to repair nerve tissue.
Related Companies
Companies in the same industry (SIC: 2836)
Kodiak Sciences Inc.
KOD Biological Products, (No Diagnostic Substances)
BioAtla, Inc.
BCAB Biological Products, (No Diagnostic Substances)
Alvotech
ALVO Biological Products, (No Diagnostic Substances)
Liminatus Pharma, Inc.
LIMN Biological Products, (No Diagnostic Substances)
Green Planet Bio Engineering Co. Ltd.
GPLB Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.